BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22644092)

  • 1. Combined administration of low-dose prednisolone and cyclosporine in idiopathic membranous nephropathy: Tsukuba's regimen for IMN.
    Usui J; Hirayama K; Suzuki S; Koyama A; Yamagata K
    Clin Exp Nephrol; 2012 Aug; 16(4):654-5. PubMed ID: 22644092
    [No Abstract]   [Full Text] [Related]  

  • 2. Triple therapy with single daily dose of cyclosporine in Japanese patients with idiopathic membranous nephropathy.
    Matsumoto H; Nagaoka Y; Okada T; Wada T; Gondo A; Esaki S; Hayashi A; Miyaoka Y; Nakao T
    Intern Med; 2011; 50(18):1905-10. PubMed ID: 21921367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic membranous nephropathy: back to the future?
    Ruggenenti P; Remuzzi G
    Lancet; 2013 Mar; 381(9868):706-8. PubMed ID: 23312809
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefit and cost from the long-term use of cyclosporine-A in idiopathic membranous nephropathy.
    Kalliakmani P; Koutroulia E; Sotsiou F; Vlachojannis JG; Goumenos DS
    Nephrology (Carlton); 2010 Dec; 15(8):762-7. PubMed ID: 21175962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunosuppression for membranous nephropathy.
    Hofstra J; Wetzels J
    Lancet; 2013 Jun; 381(9884):2162. PubMed ID: 23791340
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunosuppression for membranous nephropathy.
    Chen Z; Du X
    Lancet; 2013 Jun; 381(9884):2162-3. PubMed ID: 23791339
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunosuppression for membranous nephropathy.
    Gödel M; Huber TB
    Lancet; 2013 Jun; 381(9884):2161. PubMed ID: 23791337
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunosuppression for membranous nephropathy.
    Cirillo M
    Lancet; 2013 Jun; 381(9884):2161. PubMed ID: 23791336
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunosuppression for membranous nephropathy.
    Dhaun N; Kluth DC
    Lancet; 2013 Jun; 381(9884):2161-2. PubMed ID: 23791338
    [No Abstract]   [Full Text] [Related]  

  • 10. ACP Journal Club. Prednisolone plus chlorambucil preserved renal function in membranous nephropathy.
    Remuzzi G; Ruggenenti P
    Ann Intern Med; 2013 May; 158(10):JC9. PubMed ID: 23689788
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppression for membranous nephropathy - Authors' reply.
    Mathieson PW
    Lancet; 2013 Jun; 381(9884):2163. PubMed ID: 23791342
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunosuppression for progressive membranous nephropathy: a UK randomised controlled trial.
    Howman A; Chapman TL; Langdon MM; Ferguson C; Adu D; Feehally J; Gaskin GJ; Jayne DR; O'Donoghue D; Boulton-Jones M; Mathieson PW
    Lancet; 2013 Mar; 381(9868):744-51. PubMed ID: 23312808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A-induced remission of primary membranous glomerulonephritis in a child.
    Pape L; Mengel M; Offner G; Ehrich JH
    Nephrol Dial Transplant; 2004 Dec; 19(12):3207. PubMed ID: 15575018
    [No Abstract]   [Full Text] [Related]  

  • 14. Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
    Papasotiriou M; Kalliakmani P; Huang L; Gerolymos M; Goumenos DS; Johnson TS
    Nephron Clin Pract; 2012; 121(1-2):c60-7. PubMed ID: 23107829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of combined cyclosporine-prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Shuto H; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2014 Oct; 18(5):784-94. PubMed ID: 24363128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patient age and the prognosis of idiopathic membranous nephropathy.
    Yamaguchi M; Ando M; Yamamoto R; Akiyama S; Kato S; Katsuno T; Kosugi T; Sato W; Tsuboi N; Yasuda Y; Mizuno M; Ito Y; Matsuo S; Maruyama S
    PLoS One; 2014; 9(10):e110376. PubMed ID: 25330372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatomyositis associated with membranous nephropathy in a 43-year-old female.
    Akashi Y; Inoh M; Gamo N; Kinashi M; Ohbayashi S; Miyake H; Kurata N
    Am J Nephrol; 2002; 22(4):385-8. PubMed ID: 12169874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of progressive renal failure and nephrotic syndrome with azathioprine and prednisolone.
    Baker LR; Tucker B; Macdougall IC; Oommen R
    Postgrad Med J; 1997 Oct; 73(864):647-8. PubMed ID: 9497977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical outcome assessment of membranous nephropathy].
    Kumagai T; Shimizu H; Nishi T; Mise N; Tagawa H; Sugimoto T
    Nihon Jinzo Gakkai Shi; 2005; 47(8):870-5. PubMed ID: 16408431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose cyclosporine treatment in Chinese nephrotic patients with idiopathic membranous nephropathy: An uncontrolled study with prospective follow-up.
    Li J; Zhang YM; Qu Z; Zhao MH; Liu G
    Am J Med Sci; 2010 Jun; 339(6):532-6. PubMed ID: 20442650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.